Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-356.15	560.12	414.83	-224.06	-329.67
Depreciation & Amortization	696.3	660.07	638.7	629.47	552.48
Stock-Based Compensation	291.13	248.05	226.84	222	189.01
Other Adjustments	705.59	20.83	-0.36	634.67	414.64
Change in Receivables	-106.28	-21.12	-51.88	-90.14	-92.74
Changes in Inventories	-86.04	-45.54	-13.42	-49.64	-48.86
Changes in Accounts Payable	39.85	-20.07	9.6	-11.23	57.02
Changes in Accrued Expenses	77.1	86.16	-23.25	165.99	142.36
Changes in Income Taxes Payable	37.22	-14.74	25.22	-1.69	-15.52
Changes in Unearned Revenue	-	-	-	-2.09	-2.31
Changes in Other Operating Activities	57.05	-61.41	-150.71	-1.3	-87.9
Operating Cash Flow	1,356	1,396	1,092	1,272	778.51
Operating Cash Flow Growth	-2.88%	27.83%	-14.15%	63.39%	-13.46%
Capital Expenditures	-58.75	-38.07	-23.96	-29.05	-27.64
Purchases of Intangible Assets	-108.5	-	-	-25	-17.89
Purchases of Investments	-1,830	-1,305	-390.1	-61.04	-26.82
Proceeds from Sale of Investments	1,360	845	270	60	1,095
Payments for Business Acquisitions	-900.55	-10	-19	-444.15	-6,235
Proceeds from Business Divestments	28.17	-	-	53	-
Investing Cash Flow	-1,510	-508.2	-163.06	-446.23	-5,212
Long-Term Debt Issued	-	980.77	-	-	5,191
Long-Term Debt Repaid	-781	-606	-31	-582.01	-1,321
Net Long-Term Debt Issued (Repaid)	-781	374.77	-31	-582.01	3,871
Issuance of Common Stock	107.86	20.65	46.46	98.02	135.26
Repurchase of Common Stock	-200.24	-369.18	-320.71	-45.5	-35.6
Net Common Stock Issued (Repurchased)	-92.38	-348.54	-274.25	52.52	99.66
Other Financing Activities	-	-5.72	-	-	-
Financing Cash Flow	-873.38	20.52	-305.25	-529.49	3,971
Effect of Exchange Rate Changes on Cash and Cash Equivalents	6.56	-1.68	1.14	-6.22	-3.21
Net Cash Flow	-1,021	906.55	624.83	290.03	-466.32
Free Cash Flow	1,297	1,358	1,068	1,243	750.87
Free Cash Flow Growth	-4.48%	27.13%	-14.07%	65.53%	-15.12%
FCF Margin	30.39%	33.37%	27.86%	33.97%	24.27%
Free Cash Flow Per Share	21.27	20.57	14.82	19.87	12.58
Levered Free Cash Flow	-374.43	1,501	846.01	-105.61	4,111
Unlevered Free Cash Flow	519.17	1,422	1,274	662.82	1,066

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q